BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SQURPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

SQURPHARMA 27-Dec-2018

Credit Rating Information and Services Limited (CRISL) has rated the Company as "AAA" in the long term and "ST-1" in the short term along with a stable outlook in consideration of its audited financials up to June 30, 2018; unaudited financials up to September 30, 2018 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

SQURPHARMA 27-Nov-2018

Trading of the shares of the Company will resume on 28.11.2018 after record date.

SQURPHARMA 26-Nov-2018

Trading of the shares of the Company will remain suspended on record date i.e., 27.11.2018.

SQURPHARMA 22-Nov-2018

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 25.11.2018 to 26.11.2018. Trading of the shares of the Company will remain suspended on record date i.e., 27.11.2018.

SQURPHARMA 14-Nov-2018

(Q1 Un-audited): Consolidated EPS was Tk. 4.30 for July-September, 2018 as against Tk. 4.08 for July-September, 2017; Consolidated NOCFPS was Tk. 4.34 for July-September, 2018 as against Tk. 5.04 for July-September, 2017. Consolidated NAV per share was Tk. 82.82 as on September 30, 2018 and Tk. 78.41 as on June 30, 2018.

SQURPHARMA 07-Nov-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2018 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2018.

SQURPHARMA 22-Oct-2018

There will be no price limit on the trading of the shares of the Company today (22.10.2018) following its corporate declaration.

SQURPHARMA 22-Oct-2018

(Continuation news of SQURPHARMA): The Company has also reported Consolidated EPS of Tk. 15.72, Consolidated NAV per share of Tk. 78.41 and Consolidated NOCFPS of Tk. 13.57 for the year ended on June 30, 2018 as against Tk. 14.43, Tk. 66.49 and Tk. 12.94 respectively for the same period of the previous year. (end)

SQURPHARMA 22-Oct-2018

The Board of Directors has recommended 36% cash and 7% stock dividend for the year ended on June 30, 2018. The Board has also approved Tk. 200.00 crore for BMRE, Capital Machinery and Lands for future expansion. Date of AGM: 20.12.2018, Time: 10:00 AM, Venue: Samson H Chowdhury Centre Dhaka Club Ltd., Ramna, Dhaka. Record Date: 27.11.2018. (cont.)

SQURPHARMA 08-Oct-2018

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 21, 2018 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2018.

Previous Next page